Clinical Trials in Clackamas, United States
Locations / Clackamas, United States
Delta Trials hosts 77 clinical trials conducted in Clackamas, United States, making it a notable site of clinical research activity. These trials covering 625 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Clackamas.
77
Total Trials
625
Conditions
0
Terminated since 2020
Browse by condition (625 total)
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Sarcomatoid renal cell carcinoma 3 trialsAll Sarcomatoid renal cell carcinoma trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- All Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Lung non-small cell carcinoma 3 trialsAll Lung non-small cell carcinoma trials
- Stage ii lung cancer ajcc v8 3 trialsAll Stage ii lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 3 trialsAll Recurrent ovarian carcinoma trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- All Clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Neuroendocrine tumor g2 3 trialsAll Neuroendocrine tumor g2 trials
- Neuroendocrine neoplasm 2 trialsAll Neuroendocrine neoplasm trials
- Ovarian seromucinous carcinoma 2 trialsAll Ovarian seromucinous carcinoma trials
- Stage iii anal cancer ajcc v8 2 trialsAll Stage iii anal cancer ajcc v8 trials